Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Cristina Martin-Lorente"'
Autor:
Andres Redondo, Ana Oaknin, Maria Jesus Rubio, Maria-Pilar Barretina-Ginesta, Ana de Juan, Luis Manso, Ignacio Romero, Cristina Martin-Lorente, Andres Poveda, Antonio Gonzalez-Martin
Publikováno v:
Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-12 (2021)
Abstract Background To determine the state of current practice and to reach a consensus on recommendations for the management of advanced ovarian cancer using a Delphi survey with a group of Spanish gynecologists and medical oncologists specially ded
Externí odkaz:
https://doaj.org/article/4435579c9d8844c3aa29254dc603cf48
Autor:
Ignacio A. Romero, Nicoletta Colombo, Jessica S Brown, Eric Pujade-Lauraine, Andreas du Bois, Domenica Lorusso, Sandro Pignata, Barbara Schmalfeldt, Hiroyuki Yoshida, Cristina Martin-Lorente, Alan Barnicle, Sakari Hietanen, Edgar Petru, Isabelle Ray-Coquard, Ignace Vergote, Ingo B. Runnebaum, Dominique Berton, Magali Provansal, Phil Rowe, Pierre Lao-Sirieix, Steven Criscione
Publikováno v:
Gynecologic Oncology. 162:S26-S27
Objectives: In the Phase III PAOLA-1/ENGOT-ov25 (NCT02477644) trial, the addition of the PARP inhibitor olaparib to bevacizumab maintenance therapy led to a significant progression-free survival (PFS) benefit in patients with newly diagnosed advanced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52cf4a193b8144b3e682c4980484b5af
https://doi.org/10.1016/s0090-8258(21)00695-8
https://doi.org/10.1016/s0090-8258(21)00695-8
Autor:
O. Etxaniz, Rafael Morales-Barrera, Ismael Ghanem, Cinthya Coronado, Carlos Fernández-Teruel, Laia Capdevila, Cristina Martin Lorente, Albert Font-Pous, Daniel Castellano, J. P. Maroto, Mariano Siguero, Joan Carles, Vicente Alfaro, Cristina Suárez, Joaquim Bellmunt
Publikováno v:
Cancer Chemotherapy and Pharmacology. 73:857-867
This exploratory phase II clinical trial evaluated the antitumor activity, safety profile and pharmacokinetics of PM00104 (Zalypsis®) 3 mg/m2 1 h every 3-week intravenous infusion in patients with advanced and/or metastatic urothelial carcinoma prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e85243d1f234a4ee9dfd60f40429a7
https://doi.org/10.1007/s00280-014-2419-7
https://doi.org/10.1007/s00280-014-2419-7
Autor:
Margarita Majem, Agust Barnadas, Esther Garcia Planellas, Andrés Barba, Idoia Genua, Georgia Anguera, Cristina Martin Lorente, Cintia Gonzalez Blanco, Ana Sebio, Oscar Gallego, Mariona Riudavets, Diego Castillo, Pablo Maroto, Ana Virgili, Luis del Carpio, Antonio Lopez-Pousa, Ivana Sullivan, Carme Facundo, A. Callejo, David Páez
Publikováno v:
Journal of Clinical Oncology. 36:3064-3064
3064Background: ICIs are associated with irAEs. We describe the incidence of irAEs in patients with solid tumors receiving ICIs and its correlation with efficacy. Methods: We retrospectively analyz...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9f6f16271fbe006079dd7312b4d249c
https://doi.org/10.1200/jco.2018.36.15_suppl.3064
https://doi.org/10.1200/jco.2018.36.15_suppl.3064
Autor:
Swati Garg, Marcus O. Butler, Neesha C. Dhani, Josee-Lyne Ethier, Victor Rodriguez-Freixinos, Helen Mackay, Tracy Stockley, Cristina Martin-Lorente, Blaise A. Clarke, Amit M. Oza, Michelle K. Wilson, Lillian L. Siu, Victoria Mandilaras, Katherine Karakasis, Patricia Shaw, Stephanie Lheureux, Philippe L. Bedard, Lisa Wang, Julia V. Burnier
Publikováno v:
Journal of Clinical Oncology. 34:5550-5550
5550Background: Somatic p53 mutations (TP53m) have been reported in most high grade serous ovarian cancers (HGSOC). We aim to investigate the impact of the type of functional TP53m on prognosis and...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::550d877350793b6e929c0f501269754f
https://doi.org/10.1200/jco.2016.34.15_suppl.5550
https://doi.org/10.1200/jco.2016.34.15_suppl.5550
Autor:
S. Laframboise, Neesha C. Dhani, Sarah E. Ferguson, Lisa Wang, Victor Rodriguez-Freixinos, Stephanie Lheureux, Catherine O'Brien, Amit M. Oza, Cristina Martin Lorente, Barry P. Rosen, Jason Dodge, Joan Murphy, Helen Mackay, Anthea Lau, Marcus O. Butler, Marcus Q. Bernardini, Michelle K. Wilson
Publikováno v:
Journal of Clinical Oncology. 33:e16586-e16586
e16586 Background: Ovarian cancer (OC) is the leading cause of death from gynecological cancer and the fifth cause of cancer mortality in women in Canada. MBO is a common (20-50% incidence) and dis...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::447708aad26f9ad3ff63e18e2f9d73e1
https://doi.org/10.1200/jco.2015.33.15_suppl.e16586
https://doi.org/10.1200/jco.2015.33.15_suppl.e16586
Autor:
Victor Rodriguez-Freixinos, Lisa Wang, Cristina Martin-Lorente, Amit M. Oza, Michelle K. Wilson, Tony Panzarella, Katherine Karakasis, Stephanie Lheureux
Publikováno v:
Journal of Clinical Oncology. 33:e16584-e16584
e16584 Background: Gynecologic malignancies (GM) represent a major cause of cancer deaths. Improving outcomes of systemic therapy in GM requires development of new active anticancer drugs (AD), the...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::981a3590c4deb1a7e13b73c7958d11f6
https://doi.org/10.1200/jco.2015.33.15_suppl.e16584
https://doi.org/10.1200/jco.2015.33.15_suppl.e16584
Autor:
Gini F. Fleming, Alice P. Chen, Michelle K. Wilson, Andrea E. Wahner Hendrickson, Vanessa Speers, Karen Chang, Jacklyn Ward, Amit M. Oza, Alexander B. Olawaiye, Valerie Bowering, Katherine Karakasis, Stephanie Lheureux, Helen Mackay, Irene Brana, James D. Brenton, Johanne I Weberpals, Lisa Wang, Cristina Martin-Lorente, Neesha C. Dhani, Victor Rodriguez-Freixinos
Publikováno v:
Journal of Clinical Oncology. 33:TPS5613-TPS5613
TPS5613 Background: Platinum resistant ovarian cancer (OC) remains a therapeutic challenge. The majority of high grade serous OC (HGSOC) harbor TP53 mutations leading to increased dependency on S- ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4715f3933f758c7c9ba0211fa34c5c96
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5613
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5613
Autor:
Helen Mackay, Anca Milea, Tracy Stockley, Victor Rodriguez-Freixinos, Marcus O. Butler, Trevor J. Pugh, Stephanie Lheureux, Cristina Martin-Lorente, Jeff Bruce, Amit M. Oza, Blaise A. Clarke, Suzanne Kamel-Reid, Patricia Shaw, Neesha C. Dhani, Lisa Wang, Anthony M. Joshua, Philippe L. Bedard, Michelle K. Wilson
Publikováno v:
Journal of Clinical Oncology. 33:5589-5589
5589 Background: Recurrent endometrial cancer (EC) has a poor prognosis with few effective systemic therapies. We reviewed the outcomes of advanced EC pts in an ongoing institutional molecular prof...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d451da4132f79d0318911a7de64030b
https://doi.org/10.1200/jco.2015.33.15_suppl.5589
https://doi.org/10.1200/jco.2015.33.15_suppl.5589
Autor:
Helen Mackay, Amit M. Oza, Michelle K. Wilson, Stephen Welch, Lynda D. Roman, Lainie P. Martin, Katie Allen, John Wright, Cristina Martin-Lorente, Lisa Wang, Helen Steed, Neesha C. Dhani, Judy Quintos, Hal W. Hirte, Marcus O. Butler, Stephanie Lheureux
Publikováno v:
Journal of Clinical Oncology. 32:TPS5629-TPS5629
TPS5629 Background: Recurrent endometrial cancer (EC) has a poor prognosis with few therapeutic options. Targeting angiogenesis through VEGF inhibition has demonstrated real but limited efficacy. S...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::056b57c5b2d936cf76fd8d0ece286f05
https://doi.org/10.1200/jco.2014.32.15_suppl.tps5629
https://doi.org/10.1200/jco.2014.32.15_suppl.tps5629